blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3227455

EP3227455 - FUSION PARTNERS FOR PEPTIDE PRODUCTION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.05.2024
Database last updated on 20.07.2024
FormerThe patent has been granted
Status updated on  09.06.2023
FormerGrant of patent is intended
Status updated on  01.02.2023
FormerExamination is in progress
Status updated on  06.08.2020
FormerRequest for examination was made
Status updated on  08.09.2017
FormerThe international publication has been made
Status updated on  16.06.2017
Most recent event   Tooltip19.07.2024Lapse of the patent in a contracting state
New state(s): LU		published on 21.08.2024 [2024/34]
Applicant(s)For all designated states
Pfenex Inc.
10790 Roselle Street
San Diego, CA 92121 / US
[2023/28]
Former [2017/41]For all designated states
Pfenex Inc.
10790 Roselle Street
San Diego, CA 92121 / US
Inventor(s)01 / RETALLACK, Diane M.
13420 Carriage Road
Poway, California 92064 / US
02 / CHAPMAN, Adam
4910 Southcrest Avenue
San Diego, California 92110 / US
03 / BRUCK, Torben R.
8859 Los Coches Road
Lakeside, California 92040 / US
04 / JIN, Hongfan
11978 Caneridge Road
San Diego, California 92128 / US
 [2017/41]
Representative(s)Wichmann, Hendrik
Wuesthoff & Wuesthoff
Patentanwälte und Rechtsanwalt PartG mbB
Schweigerstraße 2
81541 München / DE
[N/P]
Former [2023/28]Wichmann, Hendrik
Wuesthoff & Wuesthoff
Patentanwälte PartG mbB
Schweigerstraße 2
81541 München / DE
Former [2017/41]Campabadal i Monfà, Gemma
Wilson Sonsini Goodrich & Rosati LLP
Rue Montoyer 47
1000 Bruxelles / BE
Application number, filing date15866061.330.11.2015
[2017/41]
WO2015US63027
Priority number, dateUS201462086119P01.12.2014         Original published format: US 201462086119 P
[2017/41]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016089782
Date:09.06.2016
Language:EN
[2016/23]
Type: A1 Application with search report 
No.:EP3227455
Date:11.10.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 09.06.2016 takes the place of the publication of the European patent application.
[2017/41]
Type: B1 Patent specification 
No.:EP3227455
Date:12.07.2023
Language:EN
[2023/28]
Search report(s)International search report - published on:US09.06.2016
(Supplementary) European search report - dispatched on:EP01.06.2018
ClassificationIPC:C12P21/04, C12P21/06, C12N1/20, C12N15/00, C12N15/67, C12N15/74, C07K14/535, C07K14/62, C07K14/635, C12N9/64
[2018/27]
CPC:
C07K14/635 (EP,KR,US); C07K14/195 (KR); C07K14/535 (EP,KR,US);
C07K14/62 (EP,KR,US); C12N9/6424 (EP,KR,US); C12Y304/21009 (EP,KR,US);
C07K2319/35 (EP,KR,US); C07K2319/50 (EP,KR,US); Y02A50/30 (EP) (-)
Former IPC [2017/41]C12P21/04, C12P21/06, C12N1/20, C12N15/00, C12N15/67, C12N15/74
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/41]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:FUSIONSPARTNER ZUR HERSTELLUNG VON PEPTIDEN[2017/41]
English:FUSION PARTNERS FOR PEPTIDE PRODUCTION[2017/41]
French:PARTENAIRES DE FUSION POUR LA PRODUCTION DE PEPTIDES[2017/41]
Entry into regional phase15.06.2017National basic fee paid 
15.06.2017Search fee paid 
15.06.2017Designation fee(s) paid 
15.06.2017Examination fee paid 
Examination procedure15.06.2017Examination requested  [2017/41]
15.06.2017Date on which the examining division has become responsible
02.01.2019Amendment by applicant (claims and/or description)
05.08.2020Despatch of a communication from the examining division (Time limit: M04)
09.12.2020Reply to a communication from the examining division
25.08.2021Despatch of a communication from the examining division (Time limit: M02)
04.11.2021Reply to a communication from the examining division
02.02.2023Communication of intention to grant the patent
01.06.2023Fee for grant paid
01.06.2023Fee for publishing/printing paid
01.06.2023Receipt of the translation of the claim(s)
Opposition(s)15.04.2024No opposition filed within time limit [2024/25]
Fees paidRenewal fee
13.11.2017Renewal fee patent year 03
14.11.2018Renewal fee patent year 04
14.11.2019Renewal fee patent year 05
13.11.2020Renewal fee patent year 06
30.11.2021Renewal fee patent year 07
13.10.2022Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCZ12.07.2023
EE12.07.2023
FI12.07.2023
HR12.07.2023
LT12.07.2023
LV12.07.2023
MC12.07.2023
NL12.07.2023
PL12.07.2023
RO12.07.2023
RS12.07.2023
SE12.07.2023
SK12.07.2023
SM12.07.2023
NO12.10.2023
GR13.10.2023
IS12.11.2023
PT13.11.2023
LU30.11.2023
[2024/34]
Former [2024/32]CZ12.07.2023
EE12.07.2023
FI12.07.2023
HR12.07.2023
LT12.07.2023
LV12.07.2023
MC12.07.2023
NL12.07.2023
PL12.07.2023
RO12.07.2023
RS12.07.2023
SE12.07.2023
SK12.07.2023
SM12.07.2023
NO12.10.2023
GR13.10.2023
IS12.11.2023
PT13.11.2023
Former [2024/23]CZ12.07.2023
EE12.07.2023
FI12.07.2023
HR12.07.2023
LT12.07.2023
LV12.07.2023
NL12.07.2023
PL12.07.2023
RO12.07.2023
RS12.07.2023
SE12.07.2023
SK12.07.2023
SM12.07.2023
NO12.10.2023
GR13.10.2023
IS12.11.2023
PT13.11.2023
Former [2024/20]FI12.07.2023
HR12.07.2023
LT12.07.2023
LV12.07.2023
NL12.07.2023
PL12.07.2023
RS12.07.2023
SE12.07.2023
SM12.07.2023
NO12.10.2023
GR13.10.2023
IS12.11.2023
PT13.11.2023
Former [2024/10]FI12.07.2023
HR12.07.2023
LT12.07.2023
LV12.07.2023
NL12.07.2023
PL12.07.2023
RS12.07.2023
SE12.07.2023
NO12.10.2023
GR13.10.2023
IS12.11.2023
PT13.11.2023
Former [2024/09]FI12.07.2023
LT12.07.2023
NL12.07.2023
SE12.07.2023
NO12.10.2023
GR13.10.2023
IS12.11.2023
Former [2024/08]LT12.07.2023
NL12.07.2023
NO12.10.2023
GR13.10.2023
Former [2024/05]NL12.07.2023
Documents cited:Search[XI]WO2006078273  (US HEALTH [US], et al) [X] 1,5,12,13 * paragraph [[0026]] - paragraph [[0032]]; figures 1-15 * * Fusion protein; paragraph [[0038]] - paragraph [[0042]]; claims 1-8 * * Methods; paragraph [[0043]] - paragraph [[0048]]; figure 12; examples 1,2; claims 12-30; table 1 * [I] 9,14,15;
 [XI]EP1873251  (CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS [DE]) [X] 1,2,5,8,9,12,13 * paragraph [[0007]] - paragraph [[0011]] * * paragraph [[0013]] - paragraph [[0017]] * * Also paragraphs [0077] and [0078]; paragraph [[0019]] - paragraph [[0024]]; figures 1-8; examples 1-4; claims 1-22 * [I] 14,15;
 [XI]  - KYRATSOUS C A ET AL, "Chaperone-fusion expression plasmid vectors for improved solubility of recombinant proteins in Escherichia coli", GENE, ELSEVIER, AMSTERDAM, NL, vol. 440, no. 1-2, doi:10.1016/J.GENE.2009.03.011, ISSN 0378-1119, (20090326), pages 9 - 15, (20090326), XP026127941 [X] 1,5,10,12,13 * abstract * * Introduction, last 2 paragraphs,;; figures 1, 2 * * Results and Discussion 3.1-3.5;; figures 3-5 * [I] 9,14,15

DOI:   http://dx.doi.org/10.1016/j.gene.2009.03.011
International search[A]WO2005069913  (DOW GLOBAL TECHNOLOGIES INC [US], et al) [A] 1-3, 5/(1-3), 11* . Especially claims 1-4 *;
 [XY]  - KYRATSOUS et al., "Chaperone-fusion expression plasmid vectors for improved solubility of recombinant proteins in Escherichia coli.", GENE, (20090701), vol. 440, no. 1-2, doi:doi:10.1016/j.gene.2009.03.011, pages 9 - 15, XP026119223 [X] 1, 2, 5/1, 5/2 * Especially abstract, pg 10 col 1 para 1, pg 11 fig 1, pg 12 col 1 para 5 * [Y] 3, 5/3, 11

DOI:   http://dx.doi.org/10.1016/j.gene.2009.03.011
 [Y]  - Uniprot I2BRJ0, (20141001), URL: http://www.uniprot.org/uniprot/I2BRJ0.txt?version=12, (20160414) [Y] 3, 5/3, 11 * . Especially pg 1. *
by applicantUS4551433
 EP0207459
 US4695455
 US4755465
 US4861595
 US5055294
 US5128130
 US5169760
 US5281532
 US5648237
 US5750374
 US5935824
 WO03010204
 US2006040352
 WO2006078273
 US7150974
 US2007292918
 EP1873251
 US2008269070
 US7476532
 US7618799
 US2010137162
 US7794972
 US7833752
 US7985564
 US8017355
 US8288127
 US8455218
 US8569015
 US8603824
 US9169304
    - KYRATSOUS et al., Gene, (20090000), vol. 440, no. 1-2, pages 9 - 15
    - JIN et al., "Crystal Structure of Human Parathyroid Hormone 1-34 at 0.9 Å Resolution", J. Biol. Chem., (20000000), vol. 275, no. 35, pages 27238 - 44, XP002976117
    - Guidebook to Molecular Chaperones and Protein-Folding Catalysts, University Press Inc., (19970000), pages 463 - 465
    - MA et al., "Correlations between Shine-Dalgarno Sequences and Gene Features Such as Predicted Expression Levels and Operon Structures", J. Bact., (20020000), vol. 184, no. 20, pages 5733 - 45
    - LICHTY et al., Comparison of affinity tags for protein purification,'' Protein Expression and Purification, (20050000), vol. 41, pages 98 - 105
    - TERPE K., "Overview of Tag Protein Fusions: from molecular and biochemical fundamentals to commercial systems", Applied Microbiology and Biotechnology, (20030000), no. 60, pages 523 - 533, XP002298417
    - WELCH et al., "Design Parameters to Control Synthetic Gene Expression in Escherichia coli", PLoS One, (20090000), vol. 4, no. 9, doi:10.1371/journal.pone.0007002, page e7002, XP002670364

DOI:   http://dx.doi.org/10.1371/journal.pone.0007002
    - J. SANCHEZ-ROMEROV. DE LORENZO, Manual of Industrial Microbiology and Biotechnology, ASM Press, (19990000), pages 460 - 74
    - H. SCHWEIZER, Current Opinion in Biotechnology, (20010000), vol. 12, pages 439 - 445
    - MANOIL, Methods in Enzymol, (20000000), vol. 326, pages 125 - 47
    - D. FRISHMAN et al., Gene, (19990708), vol. 234, no. 2, pages 257 - 65
    - B. E. SUZEK et al., Bioinformatics, (20011200), vol. 17, no. 12, pages 1123 - 30
    - O. IKEHATA et al., Eur. J. Biochem., (19890000), vol. 181, no. 3, pages 563 - 70
    - CHEN et al., "Determination of the optimal aligned spacing between the Shine-Dalgarno sequence and the translation initiation codon of Escherichia coli mRNAs", Nucleic Acids Research, (19940000), vol. 22, no. 23, pages 4953 - 4957, XP001156191
    - BARDWELL et al., Phosphate Microorg, (19940000), pages 270 - 5
    - SCHNEIDER et al., "Auxotrophic markers pyrF and proC can replace antibiotic markers on protein production plasmids in high-cell-density Pseudomonasfluorescens fermentation", Biotechnol. Progress, (20050000), vol. 21, no. 2, doi:10.1021/bp049696g, pages 343 - 8, XP002421514

DOI:   http://dx.doi.org/10.1021/bp049696g
    - "Gram(-) Proteobacteria Subgroup 1'' or ''Gram-Negative Aerobic Rods and Cocci", Bergey's Manual of Determinative Bacteriology, The Williams & Wilkins Co., (19740000), pages 217 - 289
    - DAVIS, B. D.MINGIOLI, E. S., J. Bact., (19500000), vol. 60, pages 17 - 28
    - RIESENBERG, D et al., "High cell density cultivation of Escherichia coli at controlled specific growth rate", J. Biotechnol., (19910000), vol. 20, no. 1, doi:10.1016/0168-1656(91)90032-Q, pages 17 - 27, XP023939064

DOI:   http://dx.doi.org/10.1016/0168-1656(91)90032-Q
    - RETALLACK et al., Prot. Exp. and Purif., (20120000), vol. 81, pages 157 - 165
    - NISSENSON et al., "Activation of the Parathyroid Hormone Receptor-Adenylate Cyclase System in Osteosarcoma Cells by a Human Renal Carcinoma Factor", Cancer Res, (19850000), vol. 45, pages 5358 - 5363
    - SHIMIZU et al., "Parathyroid hormone (1-14) and (1-11) analogs conformationally constrained by a-aminoisobutyric acid mediate full agonist responses via the Juxtamembrane region of the PTH-1 receptor", J. Biol. Chem., (20010000), vol. 276, doi:10.1074/jbc.M106827200, pages 49003 - 49012, XP002347602

DOI:   http://dx.doi.org/10.1074/jbc.M106827200
    - SCHNEIDER et al., "Auxotrophic markers pyrF and proC can replace antibiotic markers on protein production plasmids in high-cell-density Pseudomonas fluorescens fermentation", Biotechnol. Progress, (20050000), vol. 21, no. 2, doi:10.1021/bp049696g, pages 343 - 8, XP002421514

DOI:   http://dx.doi.org/10.1021/bp049696g
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.